Showing results (121-130 of 164) with videos related to
Sort By:
Pageof 17
Neuro-Oncology Advances|August 4, 2020
Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progressionMylan R Blomquist, Shannon Fortin Ensign, Fulvio D'Angelo, et al.Nature Cancer|March 8, 2021
Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilitiesLuciano Garofano, Simona Migliozzi, Young Taek Oh, et al.Journal of Experimental & Clinical Cancer Research : CR|November 18, 2022
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapyAndrea Anichini, Alessandra Molla, Gabriella Nicolini, et al.Journal for Immunotherapy of Cancer|May 8, 2020
Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune responseJessica Roelands, Wouter Hendrickx, Gabriele Zoppoli, et al.Molecular Therapy. Nucleic Acids|March 1, 2024
MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancerAlessia Maria Cossu, Federica Melisi, Teresa Maria Rosaria Noviello, et al.Nature Genetics|October 28, 2017
Corrigendum: A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancersDominik Glodzik, Sandro Morganella, Helen Davies, et al.Cell Reports|May 30, 2019
The Genomic and Immune Landscapes of Lethal Metastatic Breast CancerLeticia De Mattos-Arruda, Stephen-John Sammut, Edith M Ross, et al.Nature Genetics|January 24, 2017
A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancersDominik Glodzik, Sandro Morganella, Helen Davies, et al.Science (New York, N.Y.)|July 28, 2012
Transforming fusions of FGFR and TACC genes in human glioblastomaDevendra Singh, Joseph Minhow Chan, Pietro Zoppoli, et al.Cell Reports. Medicine|June 25, 2025
Impact of the tumor immune contexture in microsatellite-stable metastatic colorectal cancer treated with avelumab, cetuximab, and irinotecanNicolas Huyghe, Elena Benidovskaya, Tariq Masoodi, et al.Pageof 17